Name | DCC-2036 (Rebastinib) | CAS# | 1020172-07-9 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
DCC-2036 is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1/2. |
Get all suppliers by the below link:
DCC-2036 (Rebastinib) suppliers
2024-07-15 |
DCC-2036(Rebastinib)
Price: Inquiry |
2020-01-06 |
DCC-2036 (Rebastinib)
Price: $500.0 |
2023-09-13 |
DCC-2036
Price: ¥Inquiry |
2017-12-15 |
Rebastinib
Price: ¥Inquiry |
2020-12-08 |
DCC-2036
Price: ¥646.0 |
2023-12-26 |
DCC2036
Price: Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved